Biopharmaceuticals.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; S.476 - Maintaining Investments in New Innovation Act.
MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
JOHN MICHAEL GONZALEZ COREY MALMGREN TIMOTHY ROBINSON (Chief Counsel, House Energy & Commerce Committee (2015-2022); LD & Senior Policy Counsel, Rep. Rush (2012-2015); House Subcommittee on Commerce, Trade, & Consumer Protection (2009-2012)) JONATHON JONES BRYANT HALL JOHN KIRKLAND TWOMEY (Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015))
Chief Counsel, House Energy & Commerce Committee (2015-2022); LD & Senior Policy Counsel, Rep. Rush (2012-2015); House Subcommittee on Commerce, Trade, & Consumer Protection (2009-2012) Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015)